Marilia Barros

Oct 22, 2024 | cellandgene.com | Marilia Barros |Amber Sherrick |Derek Pendlebury |Josh Russell

Webinar: Revolutionizing Cell Therapy Manufacturing With AI: Precision, Efficiency, And BeyondThe webinar will explore how AI is transforming cell therapy manufacturing by optimizing processes, enabling real-time monitoring, and enhancing quality control. It will cover AI applications in process development, improving efficiency, and personalizing treatments.

Oct 8, 2024 | outsourcedpharma.com | Marilia Barros |Louis Garguilo

By Marilia Barros, Ph.D., Regeneron The assessment and monitoring of critical quality attributes (CQAs) are fundamental in the development of adeno-associated virus (AAV)-based gene therapies, as these attributes are closely linked to product quality, safety, and efficacy. Accurate quantification of capsid titers is essential for determining appropriate dosing regimens, as the total capsid count impacts both the efficacy and safety of the therapy.

Oct 8, 2024 | cellandgene.com | Marilia Barros

By Marilia Barros, Ph.D., Regeneron The assessment and monitoring of critical quality attributes (CQAs) are fundamental in the development of adeno-associated virus (AAV)-based gene therapies, as these attributes are closely linked to product quality, safety, and efficacy. Accurate quantification of capsid titers is essential for determining appropriate dosing regimens, as the total capsid count impacts both the efficacy and safety of the therapy.